STOCK TITAN

Bausch Health Companies Inc - BHC STOCK NEWS

Welcome to our dedicated news page for Bausch Health Companies (Ticker: BHC), a resource for investors and traders seeking the latest updates and insights on Bausch Health Companies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bausch Health Companies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bausch Health Companies's position in the market.

Rhea-AI Summary
Bausch + Lomb launches $1.4 billion offering of senior secured notes and seeks to enter into an incremental term loan facility. The proceeds will fund the pending acquisition of XIIDRA® and other ophthalmology assets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
acquisition
-
Rhea-AI Summary
Bausch + Lomb launches $1.4 billion offering of senior secured notes and seeks to enter into an incremental term loan facility. The proceeds will fund the pending acquisition of XIIDRA® and other ophthalmology assets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.44%
Tags
acquisition
-
Rhea-AI Summary
Bausch + Lomb discloses financial information regarding the proposed acquisition of XIIDRA® and other ophthalmology assets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
acquisition
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
none
-
Rhea-AI Summary
Bausch Health Companies Inc. announces favorable motion ruling in Xifaxan litigation, raises revenue outlook, and provides updates on balance sheet initiatives and potential Bausch + Lomb distribution. Q2 2023 revenue of $2.17 billion, up 10% reported and 11% organically. CEO cites focus on commercial excellence and growth opportunities. R&D pipeline updates shared. Consolidated operating income increases to $412 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
earnings
Rhea-AI Summary
Bausch Health Companies Inc. and Ortho Dermatologics have announced the recipients of their 2023 Aspire Higher Scholarship program. The program has provided a total of $978,000 in scholarships since 2013 and will award six students with up to $10,000 each to pursue their undergraduate or graduate degrees. The recipients were chosen from 216 applications based on their essays and the role of healthcare professionals in treating their dermatologic conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
earnings
-
Rhea-AI Summary
Bausch Health Companies Inc. and Salix Pharmaceuticals have announced the winners of the 2023 Salix Gastrointestinal Health Scholars Program. 10 students with gastrointestinal diseases will each receive a $10,000 scholarship. The recipients were selected from over 225 applications and scholarships were awarded in four categories: Undergraduate Scholar Awards, Graduate Scholar Awards, Working Parent's Scholar Award, and Single Parent's Scholar Award.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
none
Bausch Health Companies Inc

NYSE:BHC

BHC Rankings

BHC Stock Data

3.83B
305.94M
8.18%
81.01%
6.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
CA
Laval

About BHC

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###